课题基金 / 基金详情

San Francisco Vaccine and Prevention Unit

San Francisco Vaccine and Prevention Unit
旧金山疫苗和预防单位
批准号：
8206818
负责人：
Susan Buchbinder
金额：
$137.46万
依托单位：
PUBLIC HEALTH FOUNDATION ENTERPRISES
依托单位国家：
美国
项目类别：
财政年份：
2007
资助国家：
美国
项目状态：
已结题
起止时间：
2007-03-02 至 2013-12-31
来源：
https://reporter.nih.gov/project-details/8206818
关键词：
AIDS preventionAddressCommunitiesEnrollmentFoundationsHIVHIV InfectionsHIV Vaccine Trials NetworkHIV prevention trialHIV prevention trials networkHIV vaccineHousingHuman ResourcesLeadershipMentorsMentorshipMethodsParticipantPhasePreventionPrevention ResearchPrevention strategyPublic HealthRecruitment ActivityResearchResearch PersonnelRoleSan FranciscoUnited StatesVaccineshigh riskinnovationmen who have sex with menvaccine evaluationvolunteer

项目摘要

项目成果

Susan Buchbinder的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The San Francisco Vaccine and Prevention Unit (SFVPU) provides scientific leadership, capacity to recruit study volunteers into vaccine and non-vaccine prevention trials, innovative methods for community engagement in research, and mentorship of junior investigators. We will test vaccine and prevention strategies likely to have the greatest impact in reducing HIV infection in the United States and globally through our affiliation with the HIV Vaccine Trials Network and the HIV Prevention Trials Network. The SFVPU is housed in the San Francisco Department of Public Health, using a non-profit fiscal pass-through agency, Public Health Foundation Enterprises, to provide fiscal and human-resource management.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MyPrEP Plus: Development and Pilot Testing of Novel Pre-Exposure Prophylaxis Support Tools for Transgender Women
San Francisco Bay Clinical Trial Unit: Expanding COVID-19 Testing in Heavily Impacted Communities in San Francisco
PrEP-3D: An Integrated Pharmacy Digital Diary and Delivery Strategy to Increase PrEP Use Among MSM
PrEP-3D: An Integrated Pharmacy Digital Diary and Delivery Strategy to Increase PrEP Use Among MSM
海外基金